HURA stock news · TuHURA Biosciences, Inc.
Get alerts for HURA
Follow TuHURA Biosciences, Inc. (HURA) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for HURATuHURA Biosciences, Inc. says it has taken on a new loan agreement with Parkview Holdings One LLC.
NeutralTuHURA borrowed $650,000 for general company needs, adding cash but also debt. The filing lists funding and lender-conflict risks, so it does not change the company's outlook.
12 health care stocks changed a lot in prices after the market closed on Tuesday.
NeutralTuHURA Biosciences shares rose about 7% after hours. The article gives no business reason for the move, so it does not change what we know about the company.
TuHURA Biosciences, Inc. says it has taken on a new debt of $650,000 from Parkview Holdings One LLC.
NeutralTuHURA drew $650,000 on its $50,000,000 credit line; the small draw and disclosed risks leave the company's outlook unchanged.
TuHURA Biosciences, Inc. has new directors and officers, along with new pay plans for some of them.
NeutralTuHURA adopted a 2026 inducement equity plan reserving 5,000,000 shares; it helps hiring but could shrink current owners' slices if exercised, so I read it as neutral.
TuHURA Biosciences, Inc./NV: Disclosure of a New Direct Financial Liability or Off-Balance Sheet Commitment by the Registrant (HURA).
Good for HURATuHURA Biosciences has disclosed a new direct financial obligation through a Form 8-K filing, which raises concerns about its financial health and could lead to negative investor sentiment.
TuHURA Biosciences, Inc. discloses unregistered equity securities transactions (HURA).
NeutralTuHURA Biosciences, Inc. has filed a Form 8-K detailing unregistered sales of equity securities, which could raise concerns among investors regarding dilution and regulatory compliance, potentially leading to a bearish sentiment in the market.